OTCPK:SDGC.F

Stock Analysis Report

Executive Summary

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan.

Snowflake

Fundamentals

Flawless balance sheet average dividend payer.

Share Price & News

How has SundrugLtd's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:SDGC.F

0.7%

US Consumer Retailing

-0.3%

US Market


1 Year Return

n/a

OTCPK:SDGC.F

17.8%

US Consumer Retailing

3.9%

US Market

No trading data on SDGC.F.

No trading data on SDGC.F.


Share holder returns

SDGC.FIndustryMarket
7 Day0%0.7%-0.3%
30 Day6.2%4.2%2.3%
90 Dayn/a8.7%2.3%
1 Yearn/a20.0%17.8%6.2%3.9%
3 Yearn/a39.1%30.2%46.4%36.7%
5 Yearn/a59.2%42.1%59.6%41.8%

Price Volatility Vs. Market

How volatile is SundrugLtd's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is SundrugLtd undervalued based on future cash flows and its price relative to the stock market?

24%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

SundrugLtd's share price is below the future cash flow value, and at a moderate discount (> 20%).

SundrugLtd's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

SundrugLtd is good value based on earnings compared to the US Consumer Retailing industry average.

SundrugLtd is good value based on earnings compared to the United States of America market.


Price Based on Expected Growth

SundrugLtd is poor value based on expected growth next year.


Price Based on Value of Assets

SundrugLtd is overvalued based on assets compared to the US Consumer Retailing industry average.


Next Steps

Future Growth

How is SundrugLtd expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

3.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

SundrugLtd's revenue is expected to grow by 4.6% yearly, however this is not considered high growth (20% yearly).

SundrugLtd's earnings are expected to grow by 3.6% yearly, however this is not considered high growth (20% yearly).

SundrugLtd's revenue growth is positive but not above the United States of America market average.

SundrugLtd's earnings growth is positive but not above the United States of America market average.

SundrugLtd's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

SundrugLtd is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has SundrugLtd performed over the past 5 years?

10.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

SundrugLtd's year on year earnings growth rate has been positive over the past 5 years.

SundrugLtd's 1-year earnings growth is negative, it can't be compared to the 5-year average.

SundrugLtd's 1-year earnings growth is negative, it can't be compared to the US Consumer Retailing industry average.


Return on Equity

SundrugLtd has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

SundrugLtd used its assets more efficiently than the US Consumer Retailing industry average last year based on Return on Assets.


Return on Capital Employed

SundrugLtd's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is SundrugLtd's financial position?


Financial Position Analysis

SundrugLtd is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

SundrugLtd's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

SundrugLtd has no debt.

SundrugLtd has no debt compared to 5 years ago when it was 0.6%.

SundrugLtd has no debt, it does not need to be covered by operating cash flow.

SundrugLtd has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

SundrugLtd has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is SundrugLtd's current dividend yield, its reliability and sustainability?

2.40%

Expected Dividend Yield


Dividend Yield and Payments Analysis

SundrugLtd's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.43%).

SundrugLtd's dividend is below the markets top 25% of dividend payers in United States of America (3.76%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (3.1x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of SundrugLtd's salary, the management and board of directors tenure and is there insider trading?

5.9yrs

Average management tenure


CEO

Akao Kimiya (54yo)

5.9yrs

Tenure

Mr. Akao Kimiya has been the President of Sundrug Co., Ltd since August 2013 and serves as its General Manager of Business Administration. Mr. Kimiya served as the General Manager of Administrative Divisi ...


Management Age and Tenure

5.9yrs

Average Tenure

54yo

Average Age

The average tenure for the SundrugLtd management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

9.1yrs

Average Tenure

54.5yo

Average Age

The tenure for the SundrugLtd board of directors is about average.


Insider Trading

No 3 month individual insider trading information.


Ownership Breakdown


Management Team

  • Tsuruta Kazuhiro (54yo)

    Chief of Office of President

    • Tenure: 5.9yrs
  • Akao Kimiya (54yo)

    President

    • Tenure: 5.9yrs
  • Sakai Yoshimitsu (55yo)

    Manager of Store Development Department & Director

    • Tenure: 14.3yrs

Board Members

  • Takashi Tada (50yo)

    Director

  • Sakai Yoshimitsu (55yo)

    Manager of Store Development Department & Director

    • Tenure: 9.1yrs
  • Tsuruta Kazuhiro (54yo)

    Chief of Office of President

    • Tenure: 19.1yrs
  • Kenji Fujiwara (73yo)

    External Director

    • Tenure: 4.1yrs
  • Akao Kimiya (54yo)

    President

    • Tenure: 17.1yrs
  • Sadakata Hiroshi (49yo)

    Director

    • Tenure: 11.1yrs
  • Saitsu Tatsuro (71yo)

    Chairman of the Board

    • Tenure: 5.9yrs
    • Compensation: ¥130.00m
  • Ozawa Tetsuro (61yo)

    External Auditor

    • Tenure: 7.1yrs
  • Nobuhiko Sugiura (53yo)

    External Director

    • Tenure: 5.1yrs
  • Tada Naoki (57yo)

    Director

    • Tenure: 18.1yrs

Company Information

Sundrug Co.,Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sundrug Co.,Ltd.
  • Ticker: SDGC.F
  • Exchange: OTCPK
  • Founded: 1957
  • Industry: drug retail
  • Sector: consumer retailing
  • Market Cap: JP¥350.700b
  • Listing Market Cap: JP¥3.254b
  • Shares outstanding: 116.90m
  • Website: Click here

Number of Employees


Location

  • Sundrug Co.,Ltd.
  • 1-38-1 Wakamatsu-machi
  • Fuchu
  • Tokyo
  • 183-0005
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
9989TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYAug 1994
SDGC.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDAug 1994

Biography

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores. The company was founded in 1957 and is headquartered in Fuchu, Japan. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/07/19 00:21
End of Day Share Price2019/06/28 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.